Introduction
Apart from Th1 and Th2 cells, newer subsets of CD4 + T cells have been recently described, including Th17 cells expressing IL-17 and Th22 cells expressing IL-22. Th17 cells are cells that express the prototypical cytokine --IL-17 and are known to play a major role in defense against extracellular pathogens as well as being involved in a variety of inflammatory and autoimmune diseases [158] . Recently, Th17 cells have been classified into different subsets with each subset playing a specialized role in resistance to different infections [159] .
Th22 cells are cells that express the prototypical cytokine -IL-22 and are thought to play an important role in protection against intestinal pathogens [160] . In addition, similar to Th17 cells, Th22 cells have also been linked to various inflammatory and autoimmune diseases [161] . TGF ", IL-1 ", IL-6 and IL-23 are major players driving Th17 and Th22 responses in mice and humans [162] .
Studies using animal models of lymphatic disease have clearly delineated an important role for T cells in the development of disease [32, 151] . Moreover, T cells have also been shown to play a role in human lymphatic disease, with the presence of abnormal T cell infiltrates exhibiting a biased TCR repertoire at the site of inflammation [78, 163] as well as altered chemokine receptor and activation marker expression in peripheral blood [153, 164, 165] . In terms of T cell responses, filarial disease has been associated with increased frequencies of CD4 + T cells expressing IFN# in response to parasite but not non-parasite ! )+! antigens [155] as well as markers of Type 17 responses [79] . However, very little is known about the regulation of Th17 or Th22 cells in filarial infections.
Since Th17 and Th22 cells are clearly important in the pathological manifestations of autoimmune and other diseases, we sought to determine the expression pattern of CD4 + Th17 and Th22 cells and their subsets in filarial infections. Our data reveal an important association of expansion of Th17 and Th22 cells with the presence of lymphedema in filarial infections.
In addition, our data also reveal that IL-1, IL-23 and TGF-" are cytokines that are important in regulation of these cell types in filarial disease.
Study population
We studied a group of 33 individuals with filarial lymphedema (hereafter CP), 25 clinically asymptomatic, filarial infected (hereafter INF) individuals and 15 uninfected, endemic normal (hereafter UN) individuals in an area endemic for LF in Tamil Nadu, South India. All CP individuals were circulating filarial antigen negative by both the ICT filarial antigen test (Binax, Portland, ME) and the TropBio Og4C3 enzyme-linked immunosorbent assay (ELISA) (Trop Bio Pty. Ltd, Townsville, Queensland, Australia), indicating a lack of current active infection. . The diagnosis of prior filarial infection was made by history and clinical examination as well as positive Brugia malayi antigen (BmA) -specific IgG4.
BmA-specific IgG4 and IgG ELISA were performed. All INF individuals tested positive for active infection by both the ICT filarial antigen test and the TropBio Og4C3 ELISA and had not received any anti-filarial treatment prior to this study. All UN individuals were circulating filarial antigen negative and without any signs or symptoms of infection or disease. There were no differences between the groups in terms of demographics or socio-economic status. 
Results

CP individuals exhibit significantly higher baseline and antigen -specific frequencies of Th17 and Th22 cells
To 
IL-1 and IL-23 receptor blockade results in significantly decreased frequencies of Th17 and Th22 cells in CP individuals
To identify the role of cytokines in the regulation of Th17 and Th22 cells in filarial lymphedema, we measured the frequency of Th17 and Th22 cells CP individuals (n=10) following in vitro blockade or neutralization of IL-1, IL-23, TGF-" , IL-10 and TNF signaling and concomitant stimulation with BmA. As shown in Figure 6 .3.A, CP individuals blockade and significantly increased net frequencies of Th22 cells following TGF-" and IL-10 neutralization (Figure 6.3.B) . Thus, the filarial lymphatic disease is characterized by an IL-1 and IL-23 dependent expansion of Th17 and Th22 cells. Our study also provides evidence for an important role for upstream cytokines in the regulation of Th17 and Th22 cells in filarial infections. We have previously shown that filarial infection and/or disease is associated with high systemic levels of IL-1", TNF-!, IL-23, TGF-" and IL-10 [180]. While it is well known that TGF-" along with IL-6, IL-1" and IL-23 plays a major role in the regulation of Th17 cells [181] , the identity of the cytokines involved in the regulation of Th22 cells is not well defined. It has been proposed that IL-6 in the absence of TGF-" is an important inducer of Th22 cells [160] . Our data clearly reveal that IL-1, IL-23, TGF-" and TNF-! play an important role in the expansion of Th17 cells in filarial pathology.
Discussion
On the other hand, while IL-1 and IL-23 act as promoters of Th22 expansion in filarial pathology, TGF-" and IL-10 act as down modulators of this response. Thus, TGF-" has a diametrically opposite effect on Th17 and Th22 induction -it promotes Th17 expansion but diminishes Th22 expansion. Surprisingly, IL-10 also appears to play a role in the regulation of Th22 cells. While IL-10 blockade has been previously shown to modulate both Th1 cytokine production and T cell proliferation in infected individuals [44] , to our knowledge this is the first report on a putative role for IL-10 in the regulation of Th22 cells. IL-1 and IL-23 appear to be common factors in the induction of both Th17 and Th22 responses and IL-1-IL-23-IL-17/IL-22 cytokine axis is possibly an important pathway in the inflammation driven fibrosis in filarial lymphedema.
Our study therefore, highlights an important role for CD4 + T cell subsets in the regulation of immune responses in filarial infections and reveals an unexpected elevation in the circulating frequencies of Th17 and Th22 cells. Since fibrotic pathology is the final, common outcome of many chronic inflammatory diseases, our study of Th17 and Th22 cells in filarial disease holds important implications for other inflammatory diseases as well. Our ! )'! data suggest that targeting the IL-17/IL-22 pathway or its upstream inducers would hold promise in ameliorating pathological disease manifestations in filarial infections and other pathologies of similar etiology.
